Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan T Hirsch

Showing results (41-50 of 149) with videos related to

Pageof 15
Sort By:
Journal of the American College of Cardiology|May 28, 2003
Treatment of intermittent claudication with beraprost sodium, an orally active prostaglandin I2 analogue: a double-blinded, randomized, controlled trialEmile R Mohler, William R Hiatt, Jeffrey W Olin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 8, 2012
Peripheral artery disease and CKD: a focus on peripheral artery disease as a critical component of CKD carePranav S Garimella, Peter D Hart, Ann O'Hare, et al.
Journal of the American College of Cardiology|December 15, 2010
Effectiveness of a smoking cessation program for peripheral artery disease patients: a randomized controlled trialDeborah Hennrikus, Anne M Joseph, Harry A Lando, et al.
The American Journal of Cardiology|September 17, 2002
Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitusDeepak L Bhatt, Steven P Marso, Alan T Hirsch, et al.
Journal of the American Heart Association|October 5, 2017
Contemporary Primary Prevention Aspirin Use by Cardiovascular Disease Risk: Impact of US Preventive Services Task Force Recommendations, 2007-2015: A Serial, Cross-sectional StudyJeremy R Van't Hof, Sue Duval, Adrienne Walts, et al.
Journal of the American Heart Association|January 22, 2017
Lower Extremity Peripheral Artery Disease and Quality of Life Among Older Individuals in the CommunityAozhou Wu, Josef Coresh, Elizabeth Selvin, et al.
Vascular Medicine (London, England)|July 3, 2004
Randomized trial of AT-1015 for treatment of intermittent claudication. A novel 5-hydroxytryptamine antagonist with no evidence of efficacyWilliam R Hiatt, Alan T Hirsch, John P Cooke, et al.
Physical Therapy|May 16, 2015
Movement, Function, Pain, and Postoperative Edema in Axillary Web SyndromeLinda A Koehler, Anne H Blaes, Tuffia C Haddad, et al.
Plos One|December 4, 2014
Lymphedema prevalence and treatment benefits in cancer: impact of a therapeutic intervention on health outcomes and costsKimberly M Brayton, Alan T Hirsch, Patricia J O Brien, et al.
Heart (British Cardiac Society)|July 1, 2011
Risk factors and outcomes for patients with vascular disease and serious bleeding eventsMark J Alberts, Deepak L Bhatt, Sidney C Smith, et al.
Pageof 15

Showing results (41-50 of 149) with videos related to

Sort By:
Pageof 15
Journal of the American College of Cardiology|May 28, 2003
Treatment of intermittent claudication with beraprost sodium, an orally active prostaglandin I2 analogue: a double-blinded, randomized, controlled trialEmile R Mohler, William R Hiatt, Jeffrey W Olin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 8, 2012
Peripheral artery disease and CKD: a focus on peripheral artery disease as a critical component of CKD carePranav S Garimella, Peter D Hart, Ann O'Hare, et al.
Journal of the American College of Cardiology|December 15, 2010
Effectiveness of a smoking cessation program for peripheral artery disease patients: a randomized controlled trialDeborah Hennrikus, Anne M Joseph, Harry A Lando, et al.
The American Journal of Cardiology|September 17, 2002
Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitusDeepak L Bhatt, Steven P Marso, Alan T Hirsch, et al.
Journal of the American Heart Association|October 5, 2017
Contemporary Primary Prevention Aspirin Use by Cardiovascular Disease Risk: Impact of US Preventive Services Task Force Recommendations, 2007-2015: A Serial, Cross-sectional StudyJeremy R Van't Hof, Sue Duval, Adrienne Walts, et al.
Journal of the American Heart Association|January 22, 2017
Lower Extremity Peripheral Artery Disease and Quality of Life Among Older Individuals in the CommunityAozhou Wu, Josef Coresh, Elizabeth Selvin, et al.
Vascular Medicine (London, England)|July 3, 2004
Randomized trial of AT-1015 for treatment of intermittent claudication. A novel 5-hydroxytryptamine antagonist with no evidence of efficacyWilliam R Hiatt, Alan T Hirsch, John P Cooke, et al.
Physical Therapy|May 16, 2015
Movement, Function, Pain, and Postoperative Edema in Axillary Web SyndromeLinda A Koehler, Anne H Blaes, Tuffia C Haddad, et al.
Plos One|December 4, 2014
Lymphedema prevalence and treatment benefits in cancer: impact of a therapeutic intervention on health outcomes and costsKimberly M Brayton, Alan T Hirsch, Patricia J O Brien, et al.
Heart (British Cardiac Society)|July 1, 2011
Risk factors and outcomes for patients with vascular disease and serious bleeding eventsMark J Alberts, Deepak L Bhatt, Sidney C Smith, et al.
Pageof 15